UMIN-CTR Clinical Trial

Recruitment status Terminated
Unique ID issued by UMIN UMIN000025318
Receipt No. R000029122
Official scientific title of the study Laparoscopic radical hysterectomy for stage IA2, IB1, IIA1 cervical cancer (advanced medical treatment A-36)
Date of disclosure of the study information 2016/12/18
Last modified on 2017/06/29 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Laparoscopic radical hysterectomy for stage IA2, IB1, IIA1 cervical cancer (advanced medical treatment A-36)
Title of the study (Brief title) LRH-A36
Region
Japan

Condition
Condition Stage IA2, IB1, IIA1 cervical cancer
Classification by specialty
Obsterics and gynecology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To evaluate the efficacy of laparoscopic radical hysterectomy
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Disease free survival and overall survival
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Maneuver
Interventions/Control_1 Laparoscopic radiccal hysterectomy
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
70 years-old >
Gender Female
Key inclusion criteria Low risk group
Good general condition
Offical document with informed consent
Key exclusion criteria A specimen can't be retrieved outside
Adjuvant treatment is necessary
Severe cimplication
Another cancer treated
A judgement of the doctor in charge
Target sample size 20

Research contact person
Name of lead principal investigator Imari Deura
Organization Tottori university hospital
Division name Obsterrics and gynecology
Address Nishi-cho 36-1, Yoago, Tottori
TEL 0859-38-6647
Email imari@med.tottori-u.ac.jp

Public contact
Name of contact person Imari Deura
Organization Tottori university hospital
Division name Obsterrics and gynecology
Address Nishi-cho 36-1, Yoago, Tottori
TEL 0859-38-6647
Homepage URL
Email imari@med.tottori-u.ac.jp

Sponsor
Institute Tottori university hospital
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 12 Month 18 Day

Progress
Recruitment status Terminated
Date of protocol fixation
2016 Year 05 Month 09 Day
Anticipated trial start date
2016 Year 05 Month 09 Day
Last follow-up date
2017 Year 04 Month 30 Day
Date of closure to data entry
2017 Year 04 Month 30 Day
Date trial data considered complete
2017 Year 04 Month 30 Day
Date analysis concluded
2017 Year 04 Month 30 Day

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2016 Year 12 Month 18 Day
Last modified on
2017 Year 06 Month 29 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000029122